Nursing Direct Healthcare Limited Company Accounts

Nursing Direct Healthcare Limited Company Accounts


false false false false false false false false false true false false false false false false false No description of principal activity 2016-05-26 Sage Accounts Production Advanced 2017 Update 2 - FRS 10,706 10,706 303 303 10,403 xbrli:pure xbrli:shares iso4217:GBP 10202300 2016-05-26 2017-03-31 10202300 2017-03-31 10202300 bus:Director1 2016-05-26 2017-03-31 10202300 bus:Director2 2016-05-26 2017-03-31 10202300 core:AfterOneYear 2017-03-31 10202300 core:WithinOneYear 2017-03-31 10202300 core:ShareCapital 2017-03-31 10202300 core:RetainedEarningsAccumulatedLosses 2017-03-31 10202300 bus:FRS102 2016-05-26 2017-03-31 10202300 bus:AuditExempt-NoAccountantsReport 2016-05-26 2017-03-31 10202300 bus:FullAccounts 2016-05-26 2017-03-31 10202300 bus:SmallCompaniesRegimeForAccounts 2016-05-26 2017-03-31 10202300 bus:PrivateLimitedCompanyLtd 2016-05-26 2017-03-31 10202300 core:ComputerSoftware 2016-05-26 2017-03-31 10202300 core:ComputerSoftware 2017-03-31
COMPANY REGISTRATION NUMBER: 10202300
Nursing Direct Healthcare Limited
Filleted Unaudited Financial Statements
31 March 2017
Nursing Direct Healthcare Limited
Financial Statements
Period from 26 May 2016 to 31 March 2017
Contents
Page
Statement of financial position
1
Notes to the financial statements
3
Nursing Direct Healthcare Limited
Statement of Financial Position
31 March 2017
31 Mar 17
Note
£
Fixed assets
Intangible assets
4
10,403
Current assets
Debtors
5
12,948
Cash at bank and in hand
369
--------
13,317
Creditors: amounts falling due within one year
6
23,958
--------
Net current liabilities
10,641
--------
Total assets less current liabilities
( 238)
Creditors: amounts falling due after more than one year
7
43,888
--------
Net liabilities
( 44,126)
--------
Capital and reserves
Called up share capital
100
Profit and loss account
( 44,226)
--------
Members deficit
( 44,126)
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the Period ending 31 March 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the Period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Nursing Direct Healthcare Limited
Statement of Financial Position (continued)
31 March 2017
These financial statements were approved by the board of directors and authorised for issue on 20 November 2017 , and are signed on behalf of the board by:
Mr K Boyce
Mr R M Stiff
Director
Director
Company registration number: 10202300
Nursing Direct Healthcare Limited
Notes to the Financial Statements
Period from 26 May 2016 to 31 March 2017
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 1e High Street, Purley, Surrey, CR8 2AF.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are recorded at the fair value at the acquisition date.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Computer Software
-
33% straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Intangible assets
Computer software
£
Cost
Additions
10,706
--------
At 31 March 2017
10,706
--------
Amortisation
Charge for the Period
303
--------
At 31 March 2017
303
--------
Carrying amount
At 31 March 2017
10,403
--------
5. Debtors
31 Mar 17
£
Trade debtors
12,948
--------
6. Creditors: amounts falling due within one year
31 Mar 17
£
Trade creditors
23,958
--------
7. Creditors: amounts falling due after more than one year
31 Mar 17
£
Amounts owed to group undertakings and undertakings in which the company has a participating interest
43,888
--------